Protecting the Identities of Reporters of Adverse Events and Patients; Preemption of Disclosure Rules

Summary

The Food and Drug Administration (FDA) is proposing to amend its public information regulations to protect the identities of reporters and patients associated with adverse events of FDA-regulated products.